Amphastar Pharmaceuticals, Inc.

AMPH Nasdaq SEC CIK 1297184
Follow Amphastar Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $207.6M +8.2% vs same quarter last year
Net income $37.8M +117.7% vs same quarter last year
EPS, diluted $0.87 +135.1% vs same quarter last year
Operating cash flow $43.3M −17.7% vs same quarter last year
Revenue by quarter
$186.5M
$170.5M
$174.4M
$191.8M
$183.1M
$171.2M
$183.9M
$207.6M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400M$600M$800MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$719.9M$98.1M
FY24$732M$159.5M
FY23$644.4M$137.5M
FY22$499M$91.4M
FY21$437.8M$62.1M
FY20$349.8M$1.4M
FY19$322.4M$48.9M
FY18$294.7M−$5.7M
FY17$240.2M$3.6M
FY16$255.2M$9.8M
FY15$251.5M−$2.8M
FY14$210.5M−$10.7M
FY13$229.7M$11.9M
FY12$204.3M$18.1M
FY11--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20%0%20%40%60%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2549.5%19.5%13.6%
FY2451.1%28.1%21.8%
FY2354.5%30.6%21.3%
FY2249.9%21.5%18.3%
FY2145.6%16%14.2%
FY2041%3.1%0.4%
FY1940.9%0%15.2%
FY1836.3%−2.9%−1.9%
FY1737.7%−0.5%1.5%
FY1640.8%6%3.8%
FY1530.8%−2.7%−1.1%
FY1424.4%−8.5%−5.1%
FY1337.9%7.6%5.2%
FY1244.2%12.4%8.9%
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$50M$0$50M$100M$150M$200MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$121.2M
FY24$172.3M
FY23$145.3M
FY22$65.1M
FY21$70.5M
FY20$23.4M
FY19$207K
FY18−$8.6M
FY17$4.1M
FY16$17.2M
FY15−$5.3M
FY14$553K
FY13$13.4M
FY12−$24.8M
FY11-
Returned to shareholdersDividends paid and shares bought back
$0$25M$50M$75M$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$75.6M
FY24$85.5M
FY23$58.1M
FY22$39.9M
FY21$28.9M
FY20$24.4M
FY19$22.3M
FY18$25M
FY17$30.7M
FY16$9.9M
FY15$9.9M
FY14$345K
FY13$199K
FY12$811K
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Amphastar Pharmaceuticals
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAmphastar PharmaceuticalsHealthcare median
FY2513.6%−30.6%
FY2421.8%−47%
FY2321.3%−58%
FY2218.3%−80.4%
FY2114.2%−71.8%
FY200.4%−62.2%
FY1915.2%−46.2%
FY18−1.9%−49.6%
FY171.5%−45.9%
FY163.8%−36%
FY15−1.1%−37.8%
FY14−5.1%−35.5%
FY135.2%−37.1%
FY128.9%−29.1%
FY11-−27.9%